LLLiang Luo

Liang Luo

*This is an algorithmically generated author record based on publicly available information.

Liang Luo has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Jing He

    Department of Rheumatology and Immunology, Peking University People’s Hospital , Beijing

    1 shared publication
  • Rui Yan

    Department of Rheumatology and Immunology Beijing Shunyi Hospital Beijing China

    1 shared publication
  • Tian-Xin Yi

    Department of Rheumatology, Traditional Chinese Medicine Hospital Dianjiang Chongqing, Chongqing 408300, China

    1 shared publication
  • Wei Liu

    Department of Orthopaedic, Traditional Chinese Medicine Hospital Dianjiang Chongqing, Chongqing 408300, China

    1 shared publication
  • Wen-Fei Leng

    Department of Rheumatology, Traditional Chinese Medicine Hospital Dianjiang Chongqing, Chongqing 408300, China

    1 shared publication
  • Xiao-Chuan Wang

    Department of Rheumatology, Traditional Chinese Medicine Hospital Dianjiang Chongqing, Chongqing 408300, China

    1 shared publication

Latest Publications

  • Ankylosing spondylitis coexisting with Clonorchis sinensis infection: A case report

    by Tian-Xin Yi, Wei Liu, Wen-Fei Leng, Xiao-Chuan Wang, Liang Luo

    BACKGROUND Ankylosing spondylitis (AS) is a chronic immune-mediated inflammatory disease. The prevailing theory links AS onset to infections in susceptible individuals. Furthermore, infections may impair the immune responses. Numerous studies have investigated links between AS and various infections-bacterial, viral, fungal, and other microorganism infections. However, limited attention has been given to the association between AS and Clonorchis sinensis (C. sinensis ) infection. CASE SUMMARY A 27-year-old male with a 10-yr history of AS presented to our hospital with inflammatory lower back pain as the primary manifestation. Ten years ago, the patient had achieved a stable condition after treatment with biological agents. However, he experienced a recurrence of lumbosacral pain with an unexplained cause 10 d before hospital admission. A lumbosacral magnetic resonance imaging (MRI) scan revealed bone marrow edema in the left sacroiliac joint, and laboratory indicators were elevated. Moreover, the presence of C. sinensis eggs was detected in the stool. The patient was prescribed praziquantel, resulting in the disappearance of C. sinensis eggs in subsequent routine stool tests and relief from lumbosacral pain. A follow-up MRI scan performed after 4 months revealed a reduction in bone marrow edema around the left sacroiliac joint. CONCLUSION C. sinensis infections could potentially trigger the exacerbation of AS. Clinicians should pay attention to investigating the presence of infections.


  • Open Access

    Clinical characteristics of rheumatic disease-associated hypophysitis: A case series and review of literature

    by Rui Yan, Yue-Bo Jin, Xue-Rong Li, Liang Luo, Xiao-Min Liu, Jing He

    Rheumatic diseases have been reported to sometimes involve the pituitary gland. This study aims to characterize the clinical features and outcomes of patients with rheumatic disease-associated hypophysitis. We used the electronic medical record system in our hospital to identify nine patients with pituitary involvement in rheumatoid disease. We summarized the clinical characteristics, radiographic findings, treatments, and clinical outcomes of the 9 patients. We also performed a systematic literature review of systemic lupus erythematosus (SLE) cases with pituitary involvement published in PubMed and Wanfang databases from 1995 to 2021, and eight patients with complete information were selected. In the nine-patient cohort, the median age was 54 years, and the spectrum of rheumatic diseases included immunoglobulin G4-related disease (IgG4RD) (4/9), SLE (2/9), vasculitis (2/9), and Sjögren syndrome (SS) (1/9). All patients had pituitary abnormalities on radiological assessment, 6 developed diabetes insipidus (DI), and 8 presented with anterior pituitary hormone deficiencies in the disease duration. All the patients had multisystem involvement. As compared to hypophysitis with IgG4RD (IgG4-H), the age at onset of hypophysitis with SLE (SLE-H) patients was younger [(30.4 ± 16.4) years vs. (56.0 ± 0.8) years] and the disease duration was shorter [(14.0 ± 17.5) months vs. (71.0 ± 60.9) months] (P < .05). All patients were managed with glucocorticoids (GC) in combination with another immunosuppressant, and the majority of patients improved within 4 months. Six patients achieved disease remission while four required at least one hormone replacement therapy. Hypophysitis is a rare complication secondary to a variety of various rheumatic diseases that can occur at any stage. GC combined with additional immunosuppressants could improve patients’ symptoms; however some patients also required long-term hormone replacement therapy in pituitary disorders.


  • 血清趋化因子CXCL-10和涎液化糖链抗原6水平在类风湿关节炎合并肺间质病变患者中的诊断和病情评估价值

    by 蕊 闫, 丹 柯, 妍 张, 丽 李, 焕然 苏, 伟 陈, 明霞 孙, 晓敏 刘, 靓 罗

    检测CXC趋化因子配体10(CXC motif chemokine 10, CXCL-10)和涎液化糖链抗原6(Krebs von den lungen-6, KL-6)在类风湿关节炎合并肺间质病变(rheumatoid arthritis associated interstitial lung disease, RA-ILD)患者血清中的表达水平,分析其与RA-ILD的相关性,探讨CXCL-10和KL-6对RA-ILD患者病情评价的意义。 选择2021年5月至2023年10月在北京市顺义区医院风湿免疫科住院及门诊治疗的169例类风湿关节炎(rheumatoid arthritis,RA)患者的病例资料进行回顾性分析,根据是否合并ILD分为RA-ILD组82例和RA-non-ILD组87例,根据入排标准最终筛选出两组各80例。采用酶联免疫吸附试验检测所有患者血清CXCL-10和KL-6水平,通过1 ∶ 1倾向性评分匹配法(propensity score matching, PSM)对两组患者进行匹配,得到组间协变量均衡的样本。比较匹配后的组间差异,分析血清CXCL-10、KL-6与ILD评分(Warrick评分)、临床实验室及肺功能参数之间的相关性,利用二元Logistic回归分析RA患者发生ILD的危险因素,并判断CXCL-10、KL-6对RA-ILD的预测价值。 经1 ∶ 1 PSM匹配出RA-ILD组和RA-non-ILD组患者各49例。RA-ILD组血清CXCL-10、KL-6水平显著高于RA-non-ILD组[CXCL-10水平64.36(34.01, 110.18) ng/L vs. 29.80(16.89, 40.55) ng/L,P<0.001;KL-6水平360.70(236.35, 715.05) U/mL vs. 210.69(159.98, 255.50) U/mL, P<0.001]。RA-ILD患者血清CXCL-10水平与Warrick评分呈正相关(r=0.378,P=0.007),与用力肺活量(forced vital capacity, FVC)占正常预计值的百分比(FVC%)呈负相关(r=-0.338,P=0.018);KL-6与类风湿因子(rheumatoid factor,RF)呈正相关(r=0.296,P=0.039),与FVC%(r=-0.436,P=0.002)和一氧化碳弥散量(diffusion lung carbon monoxide, DLCO)占预计值的百分比(DLCO%,r=-0.426,P=0.002)呈负相关。单因素和多因素二元Logistic回归分析均提示CXCL-10(OR值分别为1.035、1.023,P均<0.05)、KL-6水平(OR值分别为1.004、1.005,P均<0.05)与ILD呈正相关。分别用CXCL-10和KL-6绘制ROC曲线,曲线下面积分别为0.770和0.752,联合检测曲线下面积可增加至0.800。 RA-ILD患者血清CXCL-10和KL-6水平明显升高,与ILD患者ILD严重程度有一定的相关性,两者联合检测对诊断RA-ILD有较高的参考价值。